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Purpose: The cornea is the major refractive component of the eye and serves as a barrier to the external environment.
Understanding how the cornea responds to injury is important to developing therapies to treat vision disorders that affect
the integrity and refractive properties of the cornea. Thus, investigation of the wound healing responses of the cornea to
injury in a cost-effective animal model is a valuable tool for research. This study characterizes the wound healing responses
in the corneas of White Leghorn chicken.
Methods: Linear corneal wounds were induced in post-natal day 7 (P7) chicks and cellular proliferation, apoptosis and
regulation of structural proteins were assessed using immunohistochemical techniques. We describe the time course of
increased expression of different scar-related markers, including vimentin, vinculin, perlecan and smooth muscle actin.
Results: We find evidence for acute necrotic cell death in the corneal region immediately surrounding cite of incision,
whereas we failed to find evidence of delayed cell death or apoptosis. We find that the neuronal re-innervation of SV2-
positive axon terminals within the corneal stroma and epithelium occurs very quickly after the initial scarring insult. We
describe an accumulation of cells within the stroma immediately underlying the scar, which results, at least in part, from
the local proliferation of keratocytes. Further, we provide evidence for scar-induced accumulations of CD45-positive
monocytes in injured corneas.
Conclusions: We conclude that the chick cornea is an excellent model system in which to study wound healing, formation
of scar tissue, and neuronal re-innervation of sensory endings.
The cornea is a stratified, transparent, avascular tissue
which acts as a barrier to the external environment and serves
as the major refractive component of the eye. The cornea is
derived from 2 sources: the ectoderm, which provides the
corneal epithelium and stroma, and neural crest cells, which
provide keratocytes and endothelial cells [1] (reviewed by
[2]).  In  the  mature  cornea,  corneal  keratocytes  remain
quiescent until the introduction of an insult, which leads to a
cascade of cell-cell signaling and wound healing response
(reviewed  by  [3,4]).  A  response  to  insult  that  involves
production of scar tissue into the cornea can compromise the
optical properties of the cornea. Thus, the ability of the cornea
to  heal  from  damage  resulting  from  infection  or  trauma
without introducing excessive scarring is vital to maintaining
visual function.
There are multiple different animal models that are used
to  examine  corneal  wound  healing  in  response  trauma  or
surgery [5-12]. One animal model that has received relatively
little attention in corneal wound healing is the chicken. The
chicken cornea has several advantages compared to rodent
models of wound healing: 1) chickens have much larger eyes
and corneas (approximately 9 mm in diameter and 400 µm in
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thickness) than rodents, making these eyes more amenable to
experimental  manipulations  such  as  refractive  surgical
procedures, 2) the intraocular lens in the chicken is much
smaller than in the rodent model, allowing for delivery of
intravitreal injection of compounds such as BrdU without
complication 3) newly hatched chicks are inexpensive, 4)
unlike  rodents,  chicken  corneas  have  a  true  Bowman’s
membrane  and  the  corneal  layers  are  proportional  to  the
human cornea. The chick cornea is composed of 5 layers
similar to the human cornea, and the cellular composition and
the  proportional  thickness  of  the  different  layers  are
comparable to those of the human cornea [13]. Given the
similarities between chicken and human corneas, the chicken
model represents a useful animal model for examining wound
healing.
Currently, the scientific literature focuses on the response
of the chick cornea to refractive surgery techniques such as
photorefractive  keratectomy  (PRK)  and  laser  in  situ
keratomileusis (LASIK) [14-16]. The purpose of this study
was to characterize the wound healing process in chick cornea
following induced trauma. We assess the time-course of cell
death, cellular proliferation, and neuronal re-innervation. In
addition,  we  characterize  the  patterns  of  expression  of
structural  proteins  that  are  known  to  be  associated  with
corneal healing.
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Animals: Animals were used in accordance with international
standards for animal treatment established by the National
Institutes of Health, ARVO and The Ohio State University.
Newly  hatched  white  leghorn  chickens  (Gallus  gallus
domesticus) were obtained from the Ohio State University
Department of Animal Sciences (Columbus, OH) and raised
on a cycle of 12 h light, 12 h dark (light 7 AM to 7 PM) in a
stainless steel brooder. Chicks were fed Purina chick starter
(Purina, St Louis, MO) and water ad libitum.
Intraocular  injections  and  corneal  wound  generation:
Animals were anesthetized by inhalation of 2.5% isoflurane
in O2 at a flow rate of 1.5 l/min. Corneal anesthesia was
achieved  using  1  drop  of  0.5%  topical  proparacaine
ophthalmic  solution.  A  4  mm  Barraquer  pediatric  lid
speculum was inserted and the chick placed under a Leica S6E
stereo  microscope  (Leica,  Buffalo,  NY).  A  single  linear
corneal  incision  was  made,  nasal  to  temporal,  using  a
Nichamin LRI (Storz, Rochester NY) diamond knife set for a
blade depth of 0.50 mm through the central cornea with a mid-
stroma  target  depth.  After  incision,  1  drop  of  0.3%
moxifloxacin topical ophthalmic solution (Vigamox; Alcon,
Fort Worth, TX) was applied and animals were subsequently
monitored for signs of corneal infection.
Cellular proliferation was assayed by using intravitreal
injections of the thymidine analog 5-bromo-2-deoxyuridine
(BrdU). Six μg of BrdU diluted in 20 μl sterile saline was
injected into the dorsal quadrant of each eye through the
superior eyelid.
Tissue  dissection,  fixation,  and  sectioning:  Animals  were
sacrificed; the eyes were enucleated and hemisected along the
equator  of  the  eye.  Anterior  segments  were  fixed  in  4%
paraformaldehyde (PFA) + 3% sucrose in 0.1 M PB, pH 7.4
for 25 min at room temperature. Samples were washed twice
for 15 min in 0.05M phosphate buffered saline (PBS) and
cryoprotected  in  20%  sucrose  in  PBS  overnight.  Anterior
segments were placed in Optimal Cutting Temperature (OCT)
compound (Sakura Tissue Tek, Torrance, CA) medium and
freeze-mounted  onto  sectioning  blocks.  Corneal  sections,
nominally 12 microns thick, were made transversely through
the corneal wound using a Microm HR550 cryostat (Thermo
Fisher, Walldorf, Germany). Sections were thaw-mounted on
SuperFrost Plus slides (Thermo Fisher, Fairlawn, NJ) and
stored at –20 °C until immunolabeling.
Corneal whole-mounts were obtained after the anterior
segment was fixed in 4% PFA as described above. Corneas
were dissected away from anterior segments. Isolated corneas
were equilibrated in 20% sucrose in PBS and taken through 3
cycles of freezing and thawing. Cornea whole-mounts were
permeabilized using graded washes of DMSO (40%→ 60%→
80%→  100%→  80%→  60%→  40%).  Individual  corneas
were placed in 400 μl of primary antibody solution (antiserum
+ PBS + 0.2% Triton X-100 + 0.01% NaN3) and placed on a
nutating shaker overnight. The primary antibody solution was
aspirated and corneas were washed two times in PBS. Corneas
were covered with 400 μl of secondary antibody solution
(Alexa Fluor [Invitrogen, Carlsbad, CA] antiserum + PBS +
0.2% Triton X-100 + 0.01% NaN3) and placed on a nutating
shaker overnight. Slides were mounted under cover glass on
80% glycerol in water.
Immunolabeling and photography: Slides were warmed to
room temperature and ringed with rubber cement. Sections
were washed two times in 0.05 M PBS for 10 min and covered
with 250 μl of primary antibody solution (antiserum + PBS +
0.2% Triton X-100 + 0.01% NaN3 + 5% normal goat serum
or normal donkey serum) and incubated for 24 h in a covered,
humidified  chamber  at  room  temperature.  The  primary
antibodies  included:  (1)  mouse  anti-BrdU  used  at  1:80
dilution  (G3G4;  Developmental  Studies  Hybridoma  Bank
[DSHB]; University of Iowa, Iowa City, IA), (2) mouse anti-
CD45  used  at  1:200  dilution  (HIS-C7;  Cedi  Diagnostics,
Prionics AG, Zurich, Switzerland), (3) mouse anti-α-smooth
muscle actin (αSMA) used at 1:500 dilution (1A4; Sigma-
Aldrich, St Louis, MO), (4) rat anti-substance P used at 1:400
dilution (Ab6338; Abcam, Cambridge, MA), (5) mouse anti-
synaptic vesicles used at 1:1,000 dilution (SV2; DSHB), (6)
mouse anti-vimentin used at 1:80 dilution (H5; DSHB), (7)
mouse anti-vinculin used at 1:50 dilution dilution (VN3–24;
DSHB), (8) mouse anti-perlecan used at 1:50 dilution (5C9;
DSHB), and (9) rabbit anti-cleaved caspase 3 (CC3) used at
1:1,200 dilution (AF835; R&D Systems, Minneapolis, MN).
The primary antibody solution was aspirated and slides were
washed in two times in 0.05 M PBS for 10 min. Slides were
covered  with  250  μl  of  secondary  antibody  solution
(antiserum + PBS + 0.2% Triton X-100 + 0.01% NaN3) in a
covered, humidified chamber at room temperature for 1 h.
Slides were washed in PBS and cover glass mounted on 4:1
glycerol  to  water  (volume:volume).  Antigen  retrieval  was
used  to  permit  immunolabeling  for  BrdU;  sections  were
washed for 7 min in 4 M HCl. Secondary antibodies included
donkey- anti- goat- Alexa488,   goat-     anti- rabbit- Alexa488,
goat- anti- mouse-Alexa488/568, rabbit-anti-goat  Alexa488
and goat-anti-mouse-IgM-Alexa568 (Invitrogen) diluted to
1:1,000 in PBS plus 0.2% Triton X-100.
We evaluated the specificity of primary antibodies by
comparison with published examples of results and assays for
specificity. None of the observed labeling was due to non-
specific labeling of secondary antibodies or autofluorescence
because  sections  labeled  with  secondary  antibodies  alone
were devoid of fluorescence. Secondary antibodies included
goat- anti- rabbit- Alexa488/568    and      goat-       anti-         mouse-
Alexa488/568  (Invitrogen)  diluted  to  1:1000  in  PBS  plus
0.2% Triton X-100.
Labeling of dying cells: Dying cells were identified using
Terminal  deoxynucleotidyl  Transferase  Biotin-dUTP  Nick
End (TUNEL) Labeling (In situ Cell Death Kit TMR; Roche,
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manufacturer.  To  label  cells  with  compromised  plasma
membranes we applied a single topical drop (50 µl; 0.2 mM
in  saline)  of  Ethidium  Homodimer-1  (EtHD;  Live/Dead®
Cell  Viability  Assay;  Invitrogen)  shortly  (<15  min)  after
incisions were made into the cornea. Fifteen min after the
application of the EtHD the corneas were harvested and fixed,
as described above.
Microscopy, cell counts and statistics: Photos were taken
using a Leica  DM5000B microscope   and Leica  DC500   12-
megapixel cooled CCD camera. Confocal microscopy was
performed using a Zeiss LSM 510 system (Zeiss, Thornwood,
NY) at the Hunt-Curtis Imaging Facility at The Ohio State
University. Images were optimized for color, brightness and
contrast, and double-labeled images overlaid by using Adobe
Photoshop™6.0 (Adobe, San Jose, CA). Cells counts were
performed  and  statistical  analysis  completed  using  SPSS
V17.0 (IBM, Inc, Armonk, NY).
RESULTS
Cellular proliferation after corneal insult: To identify newly
generated  cells  in  the  cornea  we  injected  BrdU  into  the
vitreous chamber and harvested corneas at different times
after  BrdU-treatment.  Corneas  were  harvested  (and  BrdU
injected) at day 1 (BrdU injected 4 h prior), day 4 (BrdU
injected at days 1, 2, and 3), day 7 (BrdU injected at days 4
and 5), and day 14 (BrdU injected at days 7 and 8). Under
control conditions with no incision, BrdU-positive cells were
observed  near  the  basement  membrane  of  the  corneal
epithelium  (Figure  1A-C),  consistent  with  the  notion  that
mitotically active cells are normally found in basal epithelial
layers. In addition, we occasionally observed BrdU-positive
cells  in  the  corneal  stroma,  consistent  with  the  quiescent
nature of keratocytes in the normal cornea (Figure 1A-C).
After damage, proliferating and newly generated cells were
observed  in  the  stroma  and  epithelium  immediately
surrounding  the  corneal  incision.  One  day  after  corneal
incision, the wound was filled by a layer of epithelial cells that
were negative for BrdU (Figure 1D). By comparison, BrdU-
positive  cells  were  observed  at  the  ridge  of  the  corneal
epithelium leading into the trough caused by the incision
(Figure 1D). Few BrdU-positive cells were observed in the
corneal  stroma  immediately  below  the  epithelium  (Figure
1D). At 4 days after injury, there were no BrdU-positive cells
in the epithelium overlying the corneal incision (Figure 1E).
By comparison, there was a significant increase in BrdU-
positive cells observed within an area of hypercellularity in
the anterior stroma immediately underlying the site of incision
(Figure 1E,H). At 7 days after injury, the number of BrdU-
positive cells within the zone of injury decreased compared to
that seen at 4 days after injury (Figure 1F,H). At 14 days after
injury,  many  BrdU-positive  cells  were  observed  in  basal
layers of the epithelium in the region of the corneal incision
(Figure 1G). In addition, at day 14, we observed a few BrdU-
positive cells in the stroma at the edges of the incision site
(Figure 1G,H).
Counts of Draq5-labeled nuclei in the corneal stroma
were performed to assess the accumulation of cells following
injury.  In  control  corneas,  the  average  density  was  74.70
nuclei  per  20,000  µm2  (n=20,  SD±12.97).  There  were
significant increases in cell density in the stroma after injury
(Figure 1A-G,I). At 1 day after injury, the cell density within
the wound-region of the stroma was not significantly different
from that of control corneas (Figure 1D,I). At 4 days after
injury, there was a significant, approximate twofold increase
in cellular density in the stroma within the zone of injury
(Figure 1E-I). The increased cell density that was seen at 4
days after injury was not significantly different at 7 and 14
days after injury (Figure 1F-G,I).
It is possible that the increased cell density of stromal
cells in the corneal wound occurred due to cellular migration.
Thus, we examined whether there was a depletion of cell
density in the stromal regions immediately adjacent to the
corneal injury. There was no significant difference in stromal
cell  density  in  uninjured  corneas  compared  to  the  region
adjacent to the injury for any time point (Figure 1I). Moreover,
there was no significant change in cell density in the stromal
region adjacent to the scar, at any time point after injury
(Figure 1I).
Expression  of  filamentous  proteins  after  corneal  insult:
Following corneal incision, we found an upregulation of the
intermediate  filament  vimentin  in  stromal  cells.  Control
corneas had vimentin-immunoreactivity in most, if not all,
stromal  keratocytes  (Figure  2A),  similar  to  previous
descriptions  [17,18].  Vimentin  was  not  observed  in  the
corneal epithelial cells, whereas vimentin was observed in the
endothelial cells (Figure 2A). At 1 day after corneal incision,
vimentin  appeared  modestly  upregulated  in  stromal  cells
directly  under  the  corneal  epithelium  where  Bowman’s
membrane was disrupted (Figure 2B). At 4 days after corneal
incision,  vimentin-immunofluoresence  was  dramatically
increased in stromal cells within the wound, and these cells
extended several hundred micrometers into deeper layers of
the corneal stroma (Figure 2C). In the stromal areas lateral to
the site of incision, Bowman’s membrane appeared to remain
intact  and  the  expression  of  vimentin  was  relatively  low,
similar to levels observed in control corneas (Figure 2C). At
7  days  after  injury,  levels  of  vimentin-immunoreactivity
remained elevated, similar to levels observed at 4 days after
injury (Figure 2C,D). Levels of vimentin-immunoreactivity
remained elevated in stromal cells at 14 days after treatment,
but the stromal cells that expressed high levels of vimentin
appeared to spread laterally away from the site of incision
(Figure  2E).  Vimentin  was  not  observed  in  the  corneal
epithelium at any time point after corneal incision.
We  next  examined  the  expression  of  vinculin,  a
membrane-associated  cytoskeletal  protein,  in  damaged
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2442Figure 1. Corneal injury stimulates the proliferation of stromal cells. Transverse sections of the cornea were labeled for BrdU (green) and
Draq5 (red nuclei). Uninjured corneas (A-C) and injured corneas were harvested (and BrdU injected) at day 1 (BrdU injected 4 h prior; D),
day 4 (BrdU injected at days 1, 2, and 3; E), day 7 (BrdU injected at days 4 and 5; F), and day 14 (BrdU injected at days 7 and 8; G). Arrows
indicate BrdU-labeled nuclei. H: Plot indicating the mean (±SD; n=3 for each time point) number of BrdU-labeled cells within 20,000 µm2
within the stroma within the region of the incision. The calibration bar (50 µm) in G applies to A-G. I: Plots indicating the mean (±SD; n≥5
for each time point) indicate the mean number of stromal nuclei per 20,000 µm2 in control, undamaged corneas (red), treated stromal region
adjacent to the incision site (green), and treated stromal region within the incision site (blue). ANOVA was performed to determine significance
of difference within the data set and a Bonferroni post-hoc comparison was performed to determine significance between and within
experimental groups. There was no significant difference (p>0.05) over time among treatment groups, with the exception of between 1 and 4
days after injury within the site of incision (p=0.002; I). Abbreviations: epi – epithelium, str – stroma, endo – endothelium.
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2443Figure 2. The filamentous proteins vimentin and vinculin are upregulated in stromal cells following corneal injury. Transverse sections through
the cornea were labeled with antibodies to vimentin (A-E) or vinculin (F-J). Corneas were harvested from control eyes (A and F) or 1 day
(B and G), 4 days (C and H), 7 days (D and I) and 14 days (E and J) after injury. The calibration bar (50 µm) in J applies to all panels.
Abbreviations: epi – epithelium, str – stroma, endo – endothelium.
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2444corneas. In control corneas, vinculin was expressed at low
levels in stromal cells, whereas vinculin was not detected in
the epithelium (Figure 2F) or in the endothelium (not shown).
One day after injury, vinculin expression in the stromal cells
remained unchanged (Figure 2G). There was no vinculin-
immunofluorescence observed in the regenerated epithelium
overlying the corneal wound at any time point after injury
(Figure 2G-J). At 4 days after injury, there was a dramatic
increase in the expression of vinculin in stromal cells within
the  region  of  corneal  incision  (Figure  2H).  Vinculin
expression remained elevated in the wound-activated stromal
cells through 7 days after injury (Figure 2I). By 14 days after
injury, the expression of vinculin was decreased compared to
expression levels seen at 7 days after injury (Figure 2I,J).
However, levels of vinculin expression remained elevated at
14 days after injury compared to levels seen in controls, and
appeared to spread laterally away from the site of incision
compared to the distribution of reactive cells seen at earlier
time points (Figure 2J).
We next probed for the expression of perlecan, a heparan
sulfate proteoglycan that is associated with the endothelial
basement  membrane  in  the  cornea  [19,20].  In  untreated
corneas, perlecan was observed in the posterior cornea near
Descemet’s membrane (Figure 3A) and at high levels in the
endothelium  (data  not  shown),  consistent  with  previous
reports [21,22]. Perlecan-immunofluorescence was detected
at relatively low levels in the anterior stroma, and was not
detected in Bowman’s membrane or the epithelium (Figure
3A). At 4 h and 1 day after injury, perlecan expression in the
stroma  was  unchanged  compared  to  that  seen  in  control
corneas (Figure 3A-C). At 4 days injury, perlecan expression
was upregulated in stromal cells within the site of incision,
corresponding to the area of increased cell density (Figure
3D). At 7 days after injury, perlecan remained upregulated in
stromal cells in the area of the wound (Figure 3E). This focal
upregulation of perlecan was observed at 14 days after, but
appeared to spread laterally away from the site of incision
(Figure  3F).  We  failed  to  detect  perlecan  in  the  corneal
epithelium, which is not consistent with reports of perlecan in
the cornea of chicks and other species. The 5C9 monoclonal
antibody to perlecan recognizes domain IV. It is possible that
a splice variant of perlecan that excludes domain IV is present
in the epithelium of the chick cornea, and, therefore, was not
detected in our studies.
Antibodies to alpha-smooth muscle actin (αSMA) were
used to examine injury-induced changes in keratocytes after
corneal  injury.  In  control  chick  corneas,  αSMA  was  not
observed (Figure 3G). At 1 day after injury, αSMA was not
detectable in stromal cells (not shown). By contrast, 4 days
after injury αSMA was markedly upregulated in the stromal
cells immediately under the area of incision (Figure 3H,I). By
using confocal microscopy and 3D reconstruction, we found
αSMA surrounding the nuclei of activated corneal fibroblast-
like cells (Figure 3I). αSMA-expressing stromal cells were
present immediately posterior to Bowman’s membrane and
extended approximately 200 µm into the stroma (Figure 3H-
I). Increased levels of α-SMA-immunofluoresence continued
through 7 and 14 days after injury (not shown).
Invasion  of  immune  cells  into  injured  corneas:  Activated
macrophages are known to accumulate and participate in the
wound healing response of the stroma in damaged corneas
[23] (reviewed by [4]). To identify monocytes that invade the
cornea we applied antibodies to CD45. In undamaged corneas,
we  identified  numerous  CD45+  cells  scattered  across  the
limbal region of the cornea (Figure 4A). There were few
CD45+ cells in the stroma of undamaged corneas (Figure 4B).
At 1 day after injury, there was a significant accumulation of
CD45+ cells in anterior regions of the stroma, surrounding the
site of incision (Figure 4C). The CD45+ cells appeared to be
reactive macrophages with high levels of CD45-expression
and ameboid morphophology (Figure 4C,G) At 4 days after
injury, there were many CD45+ cells remaining within the
stroma  at  the  site  of  injury  (Figure  4D)  and  scattered
throughout  the  stroma  in  regions  adjacent  to  the  site  of
incision, across the entire cornea (Figure 4E). Within the site
of injury at 7 and 14 days after incision, the abundance of
CD45+ cells appeared diminished compared to numbers seen
at day 4 (Figure 4F,H). At 14 days after injury, the abundance
of CD45+ cells in the stroma outside of the injured region was
reduced to levels seen in undamaged corneas (Figure 4B,I).
To  determine  whether  any  of  the  CD45+  monocytes  that
accumulate in the stroma are derived through proliferation,
we probed for BrdU-labeling at 1 (BrdU injected 4 h before
harvest) and 4 days (BrdU injected at days 1, 2, and 3). We
found  very  few  of  the  CD45+  positive  monocytes  that
accumulate  within  the  stroma  in  response  to  injury  were
labeled for BrdU (Figure 4J,K). At 4 days after incision, by
comparison, we found that none of the BrdU-labeled cells that
accumulate within the injury zone of the stroma were CD45+
monocytes (Figure 4L).
Corneal  innervation  after  corneal  incision:  Branches  and
terminals of the ophthalmic branch of the trigeminal nerve
(Cranial Nerve V1) in the cornea were labeled using antibodies
to SV2, a synaptic vesicle protein. Examination of control
corneas revealed extensive neuronal processes running in the
basal layers of the epithelium in peripheral and central regions
of  the  cornea  (Figure  5A,B).  The  SV2-labeled  neuronal
processes appeared to run in bundles of axons in deeper layers
of the stroma near the limbus (Figure 5A). The axons in the
stroma appeared to ascend and terminate with numerous dense
endings in basal layers of the epithelium (Figure 5A,B). At 1
day  after  corneal  incision,  few  neuronal  processes  were
observed in the basement membrane and epithelium overlying
the wound (Figure 5C). There were neuronal processes at the
edge of the site of incision in the regenerated epithelium,
whereas there were no processes in the stroma immediately
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2445Figure 3. α-Smooth muscle actin (αSMA) and perlecan are upregulated in the stroma following corneal injury. Transverse sections of the
control (A and G) and treated (B-F, H and I) corneas were labeled with Draq5 (red nuclei) and antibodies perlecan (A-F; green) or αSMA
(G-I; green). Corneas were harvested from control eyes (A and G) or 4 h (B), 1 day (C), 4 days (D, H, and I), 7 days (E), and 14 days (F)
after injury. I is a 3D shadow reconstruction of a z-series of confocal optical sections to demonstrate the horizontal arrangement of presumptive
myofibroblasts in the stroma within injured region. Arrows indicate cells labeled for αSMA and Draq5. The calibration bar (50 µm) in F
applies to A-F, the bar in H applies to G and H, and the bar in I applies to I alone. Abbreviations: epi – epithelium, str – stroma, endo –
endothelium.
Molecular Vision 2011; 17:2440-2454 <http://www.molvis.org/molvis/v17/a265> © 2011 Molecular Vision
2446Figure 4. CD45+ monocytes accumulate in the stroma following corneal injury. Transverse section of undamaged (A and B) and injured
(C-L) corneas were labeled with Draq5 (red nuclei in A-I; blue nuclei J and L) and antibodies to CD45 (green) and BrdU (red in J and L).
Corneas were harvest at 1 (C, G, and J), 4 (D, E, and L), 7 (F), and 14 (H and I) days after injury. Panel G is a 2.5 fold enlargement of the
area (yellow box) in C indicating the amoeboid morphology of CD45+ monocytes in the site of injury in the stroma. Panel K is a 1.5 fold
enlargement of the area (yellow box) in J providing a single-channel images and a merged overlay of labeling for CD45, BrdU and Draq5 in
a single monocyte. Arrows indicate cells labeled for CD45 and Draq5, arrowheads indicate BrdU-labeled cells (J and L), and small double-
arrows indicate a single cell labeled for CD45, BrdU and Draq5 (J and K). The calibration bar (50 µm) in panel A applies to A alone, the bar
in I applies to B-I, and the bar in L applies to J and L. Abbreviations: epi – epithelium, str – stroma, endo – endothelium.
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2447underlying the injury (Figure 5C). At 4 days after injury,
numerous  SV2-positive  endings  were  present  in  the
regenerated epithelium at the edge of the incision and within
the trough of the incision (Figure 5D-J). At 7 days after injury,
SV2-positive  processes  were  observed  in  the  epithelium
overlying the site of injury (Figure 5K). At 14 days after
injury,  SV2-positive  neuronal  processes,  that  were
presumably regenerated, were observed within the injured
stromal region where the cell density was elevated (Figure
5L).
The neuropeptide substance P has been reported to be
released from the axon terminals that innervate the cornea,
and this peptide is known to regulate the proliferation and
turn-over of corneal epithelial cells (reviewed by [24]). Thus,
we probed for substance P in axons and nerve terminals that
re-innervate damaged regions of cornea. We found substance
P-immunoreactivity in all SV2-positive axons in the stroma
and terminals in the epithelium in undamaged corneas (data
not  shown).  In  addition,  we  found  substance  P-
immunoreactivity  in  the  SV2-positive  terminals  in  the
regenerated epithelium that filled the injury site at 4 days after
incision (Figure 5M-O).
Cell death after corneal injury: Examination of undamaged
corneas  revealed  no  TUNEL-positive  cells  in  the  stroma,
endothelium or epithelium (Figure 6A). After injury, TUNEL-
positive cells were observed in the corneal epithelium and
within the stroma. At 2 h after injury, numerous TUNEL-
positive cells were observed lining the border of the corneal
incision, within the epithelium and stroma that flanked the site
of incision (Figure 6B). Numbers of TUNEL-labeled cells
appeared increased at 4 h after injury (Figure 6C). At 1 day
after injury, few TUNEL-positive cells were observed in the
regenerated epithelium that filled-in the site of incision, and
no  TUNEL-positive  cells  were  observed  within  the
underlying stroma (Figure 6D). Four days after injury, we
observed  TUNEL-positive  cells  in  the  corneal  epithelium
overlying  the  wound  (Figure  6E).  Most  of  the  TUNEL-
positive  cells  were  found  in  the  superficial  layers  of  the
epithelium overlying the site of injury (Figure 6E). Very few
TUNEL-positive cells were observed in the deep layers of the
stroma within the region of the incision (Figure 6E). At 7 days
after injury, TUNEL-positive cells were not observed in the
epithelium or the stroma in damaged corneas (Figure 6F).
To compliment the data from the TUNEL studies, we
applied ethidium homodimer (EtHD) shortly (~15 min) after
injury. In undamaged corneas, EtHD does not label any cells
within the epithelium, stroma or endothelium (Figure 6H-J).
By contrast, we identified numerous dead or dying epithelial
cells, labeled with EtHD, immediately surrounding the site of
injury (Figure 6G,K-N). In addition, we found a few EtHD-
labeled cells within the stroma at the edge of the incision site
and extending as far as 40 µm into the stroma (Figure 6K-
M,O). Labeling with EtHD suggests that epithelial cells and
stromal cells die of necrosis shortly after injury. We failed to
find apoptotic cells immunolabeled for cleaved caspase 3
(CC3) within injured corneas at any time after damage (data
not shown).
DISCUSSION
Consistent with reports in other species, we find that corneal
cells  undergo  dramatic  changes  during  recovery  from  an
incision. These changes involve the epithelial and stromal
cells that surround the site of injury, neuronal re-innervation
and  monocytes  across  the  injured  cornea.  The  most
pronounced  cellular  changes  in  response  to  injury  were
observed within the stroma. The corneal stroma comprises
organized  lamellar  sheets  of  type  I  and  V  collagen,
proteoglycans,  glycoseaminoglycans  (GAGs),  and
interspersed  quiescent  keratocytes.  In  normal  corneas,
keratocytes have a flattened morphology with numerous gap
junctions, forming a syncytium of cells between the lamellar
sheets (reviewed by [3]). Keratocytes act as the caretakers of
the  corneal  stroma,  with  turnover  of  these  cells  and  the
extracellular matrix occurring at very low rate compared to
other tissues. After injury, the cornea shows a well regulated,
coordinated  response  to  re-establish  tissue  integrity  and
function. Upon damage to the epithelium, keratocytes are
exposed to several wound healing modulators produced by
corneal  epithelial  cells,  such  as  Interleukin-1  (IL-1),
Interleukin-6  (IL-6)  and  transforming  growth  factor-beta
(TGF-β). Exposure to these factors can induce apoptosis in
keratocytes in the region immediately surrounding the corneal
wound,  and  stimulate  the  proliferation  and  migration  of
nearby cells to fill-in the site of incision (reviewed by [4]).
These keratocytes transdifferentiate into fibroblasts, migrate
into  the  wound,  and  secrete  matrix  metalloproteinases,
collagenases and gelatinases to degrade the damaged collagen
and  extracellular  matrix  (ECM)  components.  These
fibroblasts secrete new ECM to fill and remodel the cornea.
Keratocytes may also differentiate into myofibroblasts, which
express α-SMA, have contractile properties, and secrete ECM
components to promote wound healing [5,25] (reviewed by
[3,4,26]).  αSMA  is  known  to  upregulated  in  corneal
keratocytes in a rodent model of corneal injury [27]. We found
that  wound  healing  involved  deposition  of  the  ECM
proteoglycan  perlecan  in  the  stroma  within  the  region  of
injury.  Consistent  with  our  findings,  accumulations  of
perlecan in the stroma have been observed following corneal
injury [16,28-30]. It is worth noting that the cellular responses
that we observed were made on animals that were between 1
and 4 weeks of age, and the responses of corneal cells in older
chicks may be different.
In response to injury, we find significant changes in the
expression of cytoskeletal filaments by reactive keratocytes
within the zone of injury. The cytoskeleton is composed of 3
classes of cellular filaments: 1) actin-based microfilaments,
2) microtubules and 3) intermediate filaments. Intermediate
Molecular Vision 2011; 17:2440-2454 <http://www.molvis.org/molvis/v17/a265> © 2011 Molecular Vision
2448Figure 5. Neuronal re-innervation of the corneal epithelium occurs rapidly after injury. Transverse sections (A-E, H-O) or whole-mount
preparations (F-J) were labeled with Draq5 (red) or antibodies to SV2 (green) and substance P (red; N and O). The inset in B is a high
magnification view of SV2-positive neuronal ending in the basal layers of the corneal epithelium. Panel E is a twofold enlargement of the
boxed-out (yellow rectangle) area in D. Panel F is a projection of confocal Z-stack of images taken from the surface of the epithelium down
to 80 µm of depth. Panel G is a projection of confocal Z-stack of images from 80 µm down to 140 µm of depth from the surface of the cornea.
Panel H is a 3D shadow reconstruction to demonstrate the arrangement of SV2-positive nerve terminals re-innervating regenerated epithelium.
Panels I and J are 20° and 90° rotations of confocal Z-stack reconstructions to demonstrate the re-innervation of the trough of regenerated
epithelium within the corneal incision. Arrows indicate SV2/substance P-positive axons in the stroma. The calibration bar (50 µm) in panel
O applies to panels A-D, K, L, and M-O. The bar in H applies to all F-H panels, the bar in I applies to I alone, the bar in J applies to J alone.
Abbreviations: epi – epithelium, str – stroma, endo – endothelium.
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2449Figure 6. Corneal incision induces the death of epithelial and stromal cells shortly after injury. Transverse sections of the cornea were labeled
for TUNEL (A-F), DAPI (I, L, N, and O), or EtHD (J, M, N, and O). Corneas were obtained at 15 min (G and K-O), 2 h (B), 4 h (C), 1 day
(D), 4 days (E) or 7 days (F) after injury. The green lines indicate Bowman’s membrane and the edge of the incision. Panel G is a whole-
mount preparation of an acutely injured cornea that was labeled with EtHD. Panels H and K are DIC images of control and damaged corneas.
Panels N and O are 2.5 fold enlargements of the boxed-out (yellow rectangles) areas in panel K. Arrows indicate the nuclei of dying cells.
The calibration bar (50 µm) in panel F applies to panels A-F, the bar in panel in G applies to G alone and the bar in panel M applies to panels
H-M. Abbreviations: epi – epithelium, str – stroma, endo – endothelium.
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2450filaments serve as a cellular scaffold that protects cells from
mechanical  stress  (reviewed  by  [31,32]).  Intermediate
filaments  are  divided  into  5  subclasses,  with  vimentin
classified as a type-III intermediate filament expressed in
mesenchymal  and  some  ectodermal  derived  cells  during
development (reviewed by [33]). In the stroma, vimentin is
expressed at low levels in undamaged corneas. After injury,
the levels of vimentin expressed in the stroma at the site of
injury increase by day 4 and remain increased through day 14.
The elevated levels of vimentin expression correspond to the
hypercellularity of the stroma, consistent with findings in
different  models  of  corneal  injury  [34-36].  The  transient
increases  in  filamentous  proteins  expressed  by  stromal
keratocytes  within  the  region  of  injury  likely  function  to
enhance the structural properties of cells to physically bridge
a wound and/or enhance the migration of cells into the wound.
Our  findings  indicate  a  rapid  regeneration  of  the
epithelium shortly after corneal incision. We did not find
BrdU-labeled cells within the regenerated epithelium when
the BrdU was applied at 20 h after injury, and we did not find
any indication of epithelial regeneration at 4 h after incision.
However, we cannot exclude the possibility that a “burst” of
proliferation  occurs  between  4  and  20  h  after  incision  to
contribute to the epithelial cells that fill the surface of the
wound. We propose that the epithelial cells that fill the wound
migrate into the trough from regions flanking the site of injury,
consistent with reports from other animal models that the re-
establishment  of  epithelial  layers  following  injury  results
primarily from movement of nearby cells into the wound
[37-40]. Only when BrdU was injected at 7 and 8 days after
injury did we observe significant numbers of proliferating
cells in basal layers of the epithelium that covered the wound,
suggesting that re-establishment of local proliferation and
turn-over epithelial cells occurs at least 1 week after injury.
Among the types of cells that migrate into the wound are
pro-inflammatory immune cells such as polymorphonuclear
leukocytes and activated macrophages (reviewed by [4]). We
find that there is a rapid, transient accumulation of CD45-
positive  monocytes  in  damaged  corneas.  These  CD45-
positive cells were most likely to be activated macrophages
given  that  these  cells  had  an  amoeboid  morphology  and
elevated levels of CD45 [41,42]. The accumulation of the
putative  macrophages  were  prominent  within  the  site  of
injury, but also included increased numbers of macrophages
across  the  entire  cornea  following  a  focal  incision.  We
detected few BrdU-labeling CD45-positive cells in damaged
corneas at 1 day after treatment, suggesting that few of the
monocytes proliferate within the stroma in response to injury.
Collectively,  these  findings  suggest  that  a  focal  incision
attracts monocytes from limbal regions of the cornea, which
normally contains numerous CD45-positive monocytes, to
migrate into the site of stromal incision.
Similar to the innervation of the cornea other species, the
avian cornea is innervated by the ophthalmic branch of the
trigeminal nerve [43]. Proper corneal innervation provides a
high-density network of touch sensitive nerve endings that are
required  to  maintain  corneal  clarity  and  integrity;  loss  of
innervation causes a disintegration of the epithelium [44-48].
We find that the neuronal re-innervation of the injured cornea
was robust, occurred rapidly (<4 days), unlike re-innervation
of the stroma which occurs more slowly (>7 days). In addition,
we find that substance P is present in the nerve terminals that
re-innervate the epithelial cells that fill the wound. This is
consistent with findings that substance P plays important roles
regulating the integrity and turn-over of corneal epithelial
cells [49-52]. The corneal epithelium regenerated in less than
24 h to fill-in the site of the incision. Our data indicate that
neuronal re-innervation followed shortly after regeneration of
the  epithelium.  The  rapid  re-innervation  likely  occurred
through sprouting and re-growth of axons and terminals. We
propose that the chick cornea is an excellent models system
in which to study axon sprouting and regeneration following
injury.
We find that corneal wound healing involves a long-
lasting increase in the density of stromal cells within the
region of the incision. Our findings suggest that the increase
in cell density occurs, at least in part, from proliferation of
local  keratocytes  within  the  stroma.  Consistent  with  this
hypothesis, we failed to detect a significant decrease in cell
density in stromal regions flanking the wound, suggesting
there was not a significant migration of keratocytes from
adjacent stromal regions into the wound. However, we cannot
exclude the possibility that stromal cells migrated into wound
from  areas  lateral  to  the  incision.  Other  studies  have
demonstrated an accumulation of stromal cells within wounds
and wound-induced proliferation of keratocytes [27,53-55].
Our  data  suggest  that  delayed,  apoptotic  cell  death
accounts  for  relatively  little  cell  loss  within  the  cornea
following an incision. We find numerous dying cells in the
epithelium and epithelium immediately flanking the site of
incision between 15 min and 4 h of injury. These findings are
consistent with necrotic cell death underlying the loss of the
cells shortly after insult, which is known to occur shortly after
injury and can be detected by labeling with TUNEL or EtHD.
We  failed  to  detect  apoptotic  corneal  cells  that  were
immunoreactive for CC3. By comparison, this antibody to
CC3 effectively labels apoptotic ganglion cells in damaged
chick retina [56], supporting the specificity of this antiserum
in chick tissues. Other models of corneal wound healing have
demonstrated significant numbers of apoptotic cells within the
stroma many days after injury [57,58](reviewed by [59]).
Conclusions—We find that the chick cornea is amenable
to experimental manipulations. Reproducible incisions were
made to the cornea and stereotypical wound healing responses
were observed within the stroma and epithelium. Following
rapid epithelial regeneration and neuronal re-innervation of
the  epithelium,  we  find  an  accumulation  of  proliferating
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2451stromal  cells  within  the  corneal  wound,  and  a  transient
accumulation  of  monocytes  across  injured  corneas  with
concentrations at the site of incision. The reactive stromal
cells expressed elevated levels of filamentous cytoskeletal
proteins and extracellular matrix molecules. We propose that
the chick cornea may serve as an outstanding model system
in  which  to  study  axonal  regeneration  and  cell-signaling
pathways that regulate wound healing.
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